Jacksonville, FLORIDA2 Active Studies

Atrial Fibrillation Clinical Trials in Jacksonville, FLORIDA

Find 2 actively recruiting atrial fibrillation clinical trials in Jacksonville, FLORIDA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
180
Enrolling

Recruiting Atrial Fibrillation Studies in Jacksonville

About Atrial Fibrillation Clinical Trials in Jacksonville

Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.

There are currently 2 atrial fibrillation clinical trials recruiting participants in Jacksonville, FLORIDA. These studies are seeking a combined 180 participants. Research is being sponsored by Incyte Corporation, Cynata Therapeutics Limited. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atrial Fibrillation Clinical Trials in Jacksonville — FAQ

Are there atrial fibrillation clinical trials in Jacksonville?

Yes, there are 2 atrial fibrillation clinical trials currently recruiting in Jacksonville, FLORIDA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Jacksonville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Jacksonville research site will contact you about next steps.

Are clinical trials in Jacksonville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Jacksonville studies also compensate for your time and travel.

What atrial fibrillation treatments are being tested?

The 2 active trials in Jacksonville are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.

Data updated March 2, 2026 from ClinicalTrials.gov